|Topic:||Antimicrobial Resistance: Issues and Options|
INSTITUTE OF MEDICINE
Division of Health Sciences Policy
Forum on Emerging Infections
Thursday, May 14, 1998 - 3:00 p.m.
216 Hart Senate Office Building
Antimicrobial Resistance: Issues and Options
As early as 1945, scientists discovered a pathogen that had developed resistance to penicillin. Since that time, antibiotic resistance has risen dramatically, posing a threat to public health, increasing medical costs, and fueling a resurgence in pathogens that were considered under control.
Fighting the problem of antibiotic resistance will require a better, more coordinated system of surveillance, as well as an increased effort to prolong the effectiveness of existing antibiotics and to develop new drugs, says a new report from the Institute of Medicine's (IOM) Forum on Emerging Infections. The report entitled, Antimicrobial Resistance: Issues and Options, summarizes the findings and opinions of participants at a recent workshop, and outlines options that policy-makers, pharmaceutical industry leaders, health officials, clinicians, researchers, and others may consider to combat this problem.
This briefing was for Members of Congress and/or congressional staff. The report was publicly released on May 14, 1998 and can be found, in its entirety, on the Web site of the National Academies Press.